Takeda: all 1,753 studies

Page 6 of 18. Open to participants first (93), then studies with results posted, then the rest; newest registration first within each.

• A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal DiseaseCompletedNCT02512068Phase 3Results posted
• Phase 1, Febuxostat XR Relative Bioavailability StudyCompletedNCT02504320Phase 1Results posted
• An Efficacy and Safety Study of Vedolizumab Intravenous (IV) Compared to Adalimumab Subcutaneous (SC) in Participants With Ulcerative ColitisCompletedNCT02497469Phase 3Results posted
• A Phase 1 Positron Emission Tomography Study to Measure Cholesterol 24S-Hydroxylase Target Occupancy of TAK-935CompletedNCT02497235Phase 1Results posted
• Azilsartan Medoxomil (TAK-491) Compared to Valsartan in Chinese Participants With HypertensionCompletedNCT02480764Phase 3Results posted
• A Study to Assess the Relative Bioavailability and to Assess the Effect of Food on the Bioavailability of a TAK-648 Tablet in Healthy ParticipantsCompletedNCT02480439Phase 1Results posted
• A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of SchizophreniaCompletedNCT02477020Phase 2Results posted
• Serologic Assay Validation, Proficiency Testing, Safety and Immunogenicity of Norovirus GI.1/GII.4 Bivalent Virus-Like Particle VaccineCompletedNCT02475278Phase 2Results posted
• Ponatinib in Participants With Resistant Chronic Phase Chronic Myeloid Leukemia (CP-CML) to Characterize the Efficacy and Safety of a Range of DosesCompletedNCT02467270Phase 2Results posted
• Safety and Efficacy Study of SHP465 in Children and Adolescents Aged 6-17 Years With Attention-Deficit Hyperactivity Disorder (ADHD)CompletedNCT02466425Phase 3Results posted
• Safety and Tolerability Study of SPD489 in Preschool Children Aged 4-5 Years, Diagnosed With Attention-deficit/Hyperactivity DisorderCompletedNCT02466386Phase 3Results posted
• Phase 1, TAK-915-1001, Single-Rising Dose, Multiple-Rising Dose, Drug-Drug Interaction, Relative Bioavailability, Food Effect, and Effect on Elderly Participants StudyCompletedNCT02461160Phase 1Results posted
• Calcichew D3 Preference Study in Participants Eligible for Calcium and Vitamin D Supplementation.CompletedNCT02457247Phase 4Results posted
• Long-term Evaluation on Height and Weight in Patients With MPS II Who Started Treatment at < 6 Years of AgeCompletedNCT02455622Phase 4Results posted
• A Phase 3 Pharmacokinetic Study of TAK-536 (Azilsartan) in Pediatric Patients 6 to Less Than 16 Years With HypertensionCompletedNCT02451150Phase 3Results posted
• Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal CancerTerminatedNCT02448810Phase 2Results posted
• Single-Dose Phase 1 Study of TAK-792CompletedNCT02448719Phase 1Results posted
• MLN3126 Single Rising Dose StudyTerminatedNCT02447458Phase 1Results posted
• TAK-648 Multiple-Rising Dose Study in Healthy Japanese Participants and Non-Japanese Participants With Type 2 Diabetes MellitusCompletedNCT02430870Phase 1Results posted
• A Study to Assess the Safety and Efficacy of Leuprorelin in Central Precocious Puberty in Chinese ParticipantsCompletedNCT02427958Phase 4Results posted
• Effect of Intravenous (IV) Vedolizumab on Mucosal Healing in Crohn's DiseaseCompletedNCT02425111Phase 3Results posted
• Safety and Immunogenicity With Two Different Serotype 2 Potencies of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Adults in SingaporeCompletedNCT02425098Phase 2Results posted
• Specified Drug-use Survey of Fomepizole Intravenous Infusion (All-case Surveillance)CompletedNCT02415712Results posted
• Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Ascending Single- and Multiple-Doses of TAK-020 in Healthy VolunteersCompletedNCT02413255Phase 1Results posted
• Study of Long Term Safety and Clinical Outcomes of Idursulfase IT and Elaprase Treatment in Pediatric Participants Who Have Completed Study HGT-HIT-094CompletedNCT02412787Phase 2/3Results posted
• A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic MalignanciesCompletedNCT02412722Phase 1Results posted
• Safety, Tolerability, Pharmacokinetic, and Efficacy Study of SPD489 in Preschool Children With Attention-deficit/Hyperactivity DisorderCompletedNCT02402166Phase 2Results posted
• A Bioequivalence Study of TAK-536 Pediatric FormulationCompletedNCT02401464Phase 1Results posted
• Bioavailability and Effect of Food on TAK-385 Tablet Formulations in Healthy ParticipantsCompletedNCT02396147Phase 1Results posted
• Panitumumab and RAS, Diagnostically-useful Gene Mutation for mCRCCompletedNCT02394795Phase 3Results posted
• Namilumab vs Adalimumab in Participants With Moderate to Severe Early Rheumatoid Arthritis Inadequately Responding to MethotrexateTerminatedNCT02393378Phase 2Results posted
• Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung CancerTerminatedNCT02393209Phase 1/2Results posted
• MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase CTerminatedNCT02391038Phase 1Results posted
• Safety, Tolerability, and Pharmacokinetics of Multiple-Dose TAK-058 in Healthy ParticipantsCompletedNCT02389881Phase 1Results posted
• A Phase 3 Study of Lu AA21004 in Patients With Major Depressive DisorderCompletedNCT02389816Phase 3Results posted
• Efficacy and Safety of Vonoprazan Compared to Lansoprazole in the Maintenance Treatment of Erosive EsophagitisCompletedNCT02388737Phase 3Results posted
• Efficacy and Safety of Oral Once-Daily Vonoprazan (TAK-438) in Participants With Erosive EsophagitisCompletedNCT02388724Phase 3Results posted
• Long-term Safety and Efficacy Outcome Study Comparing Children Previously Enrolled in Study ROPP-2008-01 for the Prevention of Retinopathy of Prematurity (ROP)CompletedNCT02386839Phase 2Results posted
• Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release CapsuleCompletedNCT02382640Phase 1Results posted
• Effects of TAK-448 in Middle-aged and Older Men With Low TestosteroneTerminatedNCT02381288Phase 2Results posted
• Dose Finding Study of Namilumab in Combination With Methotrexate in Participants With Moderate to Severe Rheumatoid Arthritis (RA)CompletedNCT02379091Phase 2Results posted
• Food Effect Study of Febuxostat XR in Healthy ParticipantsCompletedNCT02374164Phase 1Results posted
• A Phase 1, Bioequivalence Study of SYR-472 25mg and 50mg TabletsCompletedNCT02372097Phase 1Results posted
• Vortioxetine, 5, 10, and 20 mg, Relapse Prevention Study in Adults With Major Depressive Disorder (MDD)CompletedNCT02371980Phase 4Results posted
• Drug-Drug Interaction Study Between TAK-272 and Itraconazole, Digoxin or MidazolamCompletedNCT02370615Phase 1Results posted
• An [^11C]T-773 Positron Emission Tomography (PET) Study to Determine Phosphodiesterase10A Occupancy by TAK-063CompletedNCT02370602Phase 1Results posted
• A Phase 2a Pharmacodynamic Study of TAK-448 in Participants With Hypogonadotropic HypogonadismTerminatedNCT02369796Phase 2Results posted
• Phase 1/2 Study of TAK-850 Intramuscular Injection in Healthy Pediatric ParticipantsCompletedNCT02367885Phase 1/2Results posted
• Phase I Open-label Study to Evaluate Pharmacokinetics of TAK-272 in Participants With Renal or Hepatic ImpairmentCompletedNCT02367872Phase 1Results posted
• Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid TumorsTerminatedNCT02367352Phase 1Results posted
• Single-Dose Study of MT203CompletedNCT02354599Phase 1Results posted
• Dexlansoprazole in Asian Participants With Gastroesophageal Reflux DiseaseCompletedNCT02351960Phase 4Results posted
• An Extension Study to Determine Safety and Efficacy for Pediatric Patients With MPS Type IIIA Disease Who Participated in Study HGT-SAN-093.TerminatedNCT02350816Phase 2Results posted
• A Phase 1 Food Effect Study of TAK-536TCH Final Formulation TabletCompletedNCT02348658Phase 1Results posted
• Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Teduglutide in Japanese Subjects With PN-dependent Short Bowel Syndrome (SBS)CompletedNCT02340819Phase 3Results posted
• Effect of Calcium 500 mg and Vitamin D3 1000 IU Chewable Tablet on Intestinal Calcium AbsorptionCompletedNCT02338713Phase 1Results posted
• Safety and Efficacy Study of mFOLFOX6 + Panitumumab Combination Therapy and 5-FU/LV + Panitumumab Combination Therapy in Participants With Chemotherapy-naïve Unresectable Advanced Recurrent Colorectal CarcinomaCompletedNCT02337946Phase 2Results posted
• A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337764Phase 3Results posted
• A Phase 3, Long-term, Extension Study of TVP-1012 (1 mg) in Early Parkinson's Disease ParticipantsCompletedNCT02337751Phase 3Results posted
• A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease ParticipantsCompletedNCT02337738Phase 2/3Results posted
• A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease PatientsCompletedNCT02337725Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-137 in Healthy ParticipantsCompletedNCT02334982Phase 1Results posted
• A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and MicroalbuminuriaCompletedNCT02332824Phase 2Results posted
• A Study MLN2480 in Combination With MLN0128 or Alisertib, or Paclitaxel, or Cetuximab, or Irinotecan in Adult Participants With Advanced Nonhematologic MalignanciesCompletedNCT02327169Phase 1Results posted
• A Phase 4, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 4, Open-label, Long-term Study of SYR-472 (100 mg) in Combination With Insulin in Patients With Type 2 DiabetesCompletedNCT02324569Phase 3Results posted
• Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy AdultsCompletedNCT02313155Phase 1/2Results posted
• A Study of Oral Ixazomib Maintenance Therapy in Participants With Newly Diagnosed Multiple Myeloma (NDMM) Not Treated With Stem Cell Transplantation (SCT)CompletedNCT02312258Phase 3Results posted
• An Efficacy and Safety of Flomoxef Versus Cefepime in the Treatment of Participants With Urinary Tract InfectionsTerminatedNCT02302092Phase 3Results posted
• Safety and Immunogenicity of Different Schedules of Takeda's Tetravalent Dengue Vaccine Candidate (TDV) in Healthy ParticipantsCompletedNCT02302066Phase 2Results posted
• Postmarketing Clinical Study on AO-128CompletedNCT02287402Phase 4Results posted
• TAK-114 Single- and Multiple-Dose Phase 1 StudyCompletedNCT02286518Phase 1Results posted
• Specified Drug-use Survey of the Granular Capsule Formulation of Omega-3 Fatty Acid Ethyl Esters: OCEAN3CompletedNCT02285166Results posted
• AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer DiseaseTerminatedNCT02284906Phase 3Results posted
• A Study to Evaluate Efficacy and Safety of Lifitegrast in Subjects With Dry Eye (OPUS-3)CompletedNCT02284516Phase 3Results posted
• Recombinant Von Willebrand Factor in Subjects With Severe Von Willebrand Disease Undergoing SurgeryCompletedNCT02283268Phase 3Results posted
• A Phase III Long-term Study of TAK-536TCH in Participants With Essential HypertensionCompletedNCT02277691Phase 3Results posted
• Effect of Food on the Pharmacokinetics of Single Oral Dose Administration of a Fixed-Dose Combination of SYR-322 and Metformin Hydrochloride in Healthy Adult Male SubjectsCompletedNCT02276274Phase 3Results posted
• A Study to Evaluate the Effect of Itraconazole on the Pharmacokinetics of Alisertib in Participants With Advanced Solid Tumors or Relapsed/Refractory LymphomaCompletedNCT02259010Phase 1Results posted
• TAK-385 Phase I Absorption, Distribution, Metabolism, Excretion and Absolute Bioavailability StudyCompletedNCT02252354Phase 1Results posted
• Alogliptin Tablets Specified Drug-use Survey "Type 2 Diabetic Patients Receiving Combination Therapy With a Hypoglycemic Agent (e.g., Insulin Preparations or Rapid-acting Insulin Secretagogues)"CompletedNCT02221284Results posted
• A Phase 1 Study to Assess the Safety, Tolerability, and Pharmacokinetics of TAK-079 in Healthy ParticipantsCompletedNCT02219256Phase 1Results posted
• Pharmacokinetics of Alisertib in Adults With Advanced Solid Tumors or Relapsed/Refractory Lymphoma With Varying Degrees of Hepatic FunctionCompletedNCT02214147Phase 1Results posted
• Candesartan Cilexetil Special Drug Use Surveillance 「Challenge - Quality Control」CompletedNCT02211638Results posted
• BAX 855 Pediatric StudyCompletedNCT02210091Phase 3Results posted
• Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MLN3126 in Healthy Japanese and Non-Japanese ParticipantsTerminatedNCT02209506Phase 1Results posted
• A Study to Determine the Effects of NPSP795 on the Calcium-sensing Receptor in Subjects With Autosomal Dominant Hypocalcemia as Measured by PTH Levels and Blood Calcium ConcentrationsCompletedNCT02204579Phase 2Results posted
• Azilsartan Medoxomil (TAK-491) Compared to Placebo in Korean Adults With HypertensionCompletedNCT02203916Phase 3Results posted
• A Study of MLN0264 in Patients With Pancreatic CancerTerminatedNCT02202785Phase 2Results posted
• A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal JunctionTerminatedNCT02202759Phase 2Results posted
• Safety, Tolerability, and Pharmacokinetics of Escalating Single Doses of TAK-935CompletedNCT02201056Phase 1Results posted
• Safety and Immunogenicity of Three Formulations of Takeda's Tetravalent Dengue Vaccine Candidate (TDV)CompletedNCT02193087Phase 2Results posted
• Pioglitazone Tablets Specified Drug-use Survey <Survey on Glycemic Control in Type 2 Diabetic Patients With a History of Cerebral Infarction>CompletedNCT02181842Results posted
• Azilsartan/Amlodipine Combination Tablets LD & HD Specified Drug-use Survey "Long-term Use Survey"CompletedNCT02181816Results posted
• A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Participants With Multiple Myeloma Following Autologous Stem Cell TransplantCompletedNCT02181413Phase 3Results posted
• Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Ixazomib in Lupus Nephritis (LN)TerminatedNCT02176486Phase 1Results posted
• Pharmacokinetics, Safety and Tolerability of Vortioxetine in Normal Hepatic Function or Severe Hepatic ImpairmentCompletedNCT02170220Phase 1Results posted
• Takepron Intravenous 30 mg Specified Drug-use Survey [Acute Stress Ulcer and Acute Gastric Mucosal Lesions]CompletedNCT02170207Results posted
• Leuplin SR 11.25 mg Injection Kit Specified Drug-use Survey "Long-term Use Survey in Prostate Cancer Patients (96 Weeks)"CompletedNCT02167893Results posted
• Blopress Tablets Specified Drug-use Survey "Hypertension: Survey on Patients With Metabolic Syndrome"CompletedNCT02166697Results posted
• Safety, Tolerability, and Pharmacokinetics of Multiple Rising Doses of TAK-137 in Adults With Attention-Deficit/Hyperactivity Disorder.TerminatedNCT02163915Phase 1Results posted

← Takeda overview and focus areas